BMO Capital lowered the firm’s price target on Bill (BILL) to $54 from $56 and keeps a Market Perform rating on the shares. The company’s Q1 results were “good” but not great as revenue and profit upside were not too dissimilar from recent trends, the analyst tells investors in a research note. BMO adds however that evidence of improvement could come into greater clarity later in the fiscal year.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
- Bill price target lowered to $60 from $65 at UBS
- Bill price target raised to $60 from $55 at JPMorgan
- Bill price target lowered to $48 from $56 at Keefe Bruyette
- Bill.com: Resilient Growth and Emerging Innovations Drive Buy Rating
- Hold Rating on Bill.com Holdings Amid Uncertain Monetization and Competitive Challenges